1975
DOI: 10.1001/archopht.1975.01010020815015
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Experience With a Mobile Ocular Perfusion Pump

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
54
0
1

Year Published

1989
1989
2017
2017

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 81 publications
(61 citation statements)
references
References 6 publications
0
54
0
1
Order By: Relevance
“…1 Subsequently, a report 2 in the rheumatologic literature appeared in 1984 discussing the use of autologous serum as a tear substitute. Although probably used more often than it was publicized to be, the use of autologous serum for the treatment of ocular surface disorder did not appear to garner widespread interest until the late 1990s ( Figure).…”
Section: T He Use Of Autologous Serum For Treat-mentioning
confidence: 99%
“…1 Subsequently, a report 2 in the rheumatologic literature appeared in 1984 discussing the use of autologous serum as a tear substitute. Although probably used more often than it was publicized to be, the use of autologous serum for the treatment of ocular surface disorder did not appear to garner widespread interest until the late 1990s ( Figure).…”
Section: T He Use Of Autologous Serum For Treat-mentioning
confidence: 99%
“…Historically, application of autologous serum to the eyes began in 1975 with the use of an intermittently administered mobile profusion pump for 12 patients suffering from severe dry eye 25 . Patients could carry the pump with them wherever they went, giving them mobility.…”
Section: Discussionmentioning
confidence: 99%
“…Patients could carry the pump with them wherever they went, giving them mobility. Since the late 1990s, autologous serum for ophthalmic treatment has been more widely used 25 . Common indications for its use are ocular surface disorders such as Sjögren syndrome 27 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Depending on the system and on the drugs perfused, complications have included infection, crystallization and sludging of the drug within the tubing, and slippage of the tubing. 99 Animal experiments suggest that implantable pumping devices may have practical application in the delivery of drugs to the eye. In some systems the implanted fluid reservoir can be refilled by a percutaneous injection through a self-sealing rubber septum, thus circumventing the inconvenience of carrying an exposed pump.…”
Section: Mobile Systemsmentioning
confidence: 99%